Segmentation by type classifies Infusion Pump Software into five functional families: standalone software, integrated (embedded) software, cloud‑based platforms, mobile application interfaces, and clinical decision‑support modules. Standalone software, typically installed on dedicated workstations, captures about 25% of market value, serving legacy systems that require isolated operation. Integrated software, embedded directly within pump hardware, commands the largest share at 35%, reflecting manufacturers' preference for seamless device‑software coupling that enhances safety and compliance. Cloud‑based platforms, responsible for roughly 20% of revenue, enable centralized data analytics, firmware updates, and multi‑site coordination, appealing to large health networks. Mobile application interfaces, at 12%, provide bedside clinicians with real‑time control and alerts via tablets or smartphones, supporting point‑of‑care efficiency. Clinical decision‑support modules, contributing the remaining 8%, embed dosing algorithms and adverse‑event warnings, thereby augmenting therapeutic accuracy. This market taxonomy clarifies how each software type adds distinct value streams to the overall Infusion Pump Software market.